The Value Signal — July 02, 2026

629 articles scanned · 15 high-signal

Signal Map

Executive Summary

The day’s pattern is unmistakable: VBC is moving from growth story to audit regime, with Stars, coding intensity, and model design becoming the new battlegrounds for margin and legitimacy.

Medicare Advantage and Stars pressure is intensifying as CMS recalculations reshape plan economics, with Avalere Health analyzing what may follow the Clover litigation and 2027 Quality Bonus Payment recalculation, while Becker's Payer reports a Florida payer gained a third 5-star Medicare Advantage plan after CMS recalculation. KFF reports Medicare will spend more than $13 billion on the Medicare Advantage Quality Bonus Program in 2026 and separately frames coding intensity as a core Medicare Advantage risk-adjustment issue, while Health Affairs argues Medicare Advantage’s approach to pricing risk is broken.

Operational burden and model redesign are now the practical constraint on VBC execution: Medical Economics reports House efforts to simplify quality reporting requirements for overwhelmed ACOs, while Acc reports the American College of Cardiology is urging changes as the Ambulatory Specialty Model approaches. Fierce Healthcare highlights the ACCESS Model’s behavioral health edition, Home Health Care News reports Bayada’s new CEO plans to scale through value-based risk beyond payer contracts, and Strivehealth points to a Health Care Transformation Task Force case study on earlier identification, smarter coordination, and risk-aligned kidney care partnerships. American Hospital Association reports CMS proposed CY 2027 home health payment updates alongside provider enrollment, quality, and value-based purchasing changes, and Apg reports on health outcomes for socially vulnerable populations across Medicare payment arrangements.